Form D · Biotechnology
Ibex Biosciences, Inc.
Rockville, MD · CIK 0001798553
Offering snapshot reported Feb 20, 2025 · SEC filing
- Reported sold
- $70K Offering amount: $12.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2025 | Initial | $70,000 | No comparison | 3 | SEC filing |
| Jul 15, 2021 | Initial | $1,000,000 | No comparison | Not reported | SEC filing |
| Jan 2, 2020 | Initial | $2,400,000 | No comparison | 15 | SEC filing |
| Jan 2, 2020 | Initial | $1,765,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538759
Source: Form D, filed Feb 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alberto Murat Croci | Director, Executive |
| Roy Feinson | Director |
| Michael Joseph Karlin | Director, Executive |
| Sylvan Isaac Karlin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9610 Medical Center Drive
Rockville, MD, 20850
Rockville, MD, 20850